Your browser doesn't support javascript.
loading
Phosphatidylserine eversion regulated by phospholipid scramblase activated by TGF-ß1/Smad signaling in the early stage of kidney stone formation.
Gan, Xiu Guo; Xu, Hai Tao; Wang, Zhi Hao.
Afiliação
  • Gan XG; Department of Urology, First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China. ganxiuguo@qq.com.
  • Xu HT; Department of Urology, First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China.
  • Wang ZH; Department of Urology, First Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, China.
Urolithiasis ; 50(1): 11-20, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34860265
ABSTRACT
The mechanism underlying phosphatidylserine eversion in renal tubule cells following calcium oxalate-mediated damage remains unclear; therefore, we investigated the effects of TGF-ß1/Smad signaling on phosphatidylserine eversion in the renal tubule cell membrane during the early stage of kidney stone development. In a rat model of early stage of calcium oxalate stone formation, phosphatidylserine eversion on the renal tubular cell membrane was detected by flow cytometry, and the expression of TGF-ß1 (transforming growth factor-ß1), Smad7, and phospholipid scramblase in the renal tubular cell membrane was measured by western blotting. We observed that the TGF-ß1/Smad signaling pathway increased phosphatidylserine eversion at the organism level. The results of in vitro studies demonstrated that oxalate exposure to renal tubule cells induced TGF-ß1 expression, increasing phospholipid scramblase activity and phosphatidylserine eversion in the renal tubule cell membrane. These results indicate that TGF-ß1 stimulates phosphatidylserine eversion by increasing the phospholipid scramblase activity in the renal tubule cell membrane during the early stage of kidney stone development. The results of this study form a basis for further detailed research on the development of therapeutic agents that specifically treat urolithiasis and exert fewer adverse effects.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cálculos Renais / Fator de Crescimento Transformador beta1 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cálculos Renais / Fator de Crescimento Transformador beta1 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article